Androgen-Deprivation Therapy and Risk for Colorectal Cancer

Androgen-Deprivation Therapy and Risk for Colorectal Cancer Androgen-deprivation therapy (ADT) is the standard initial treatment for men with metastatic prostate cancer, yet the majority of men in the US who receive ADT have nonmetastatic disease. Recently, the FDA asked the manufacturers of gonadotropin-releasing hormone (GnRH) agonists to include warnings about the potential risks for diabetes […]

read more
Page 24 of 36« First...1020«2223242526»30...Last »